Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
119-s-832119th CongressWALLET
EPIC Act of 2025
Sponsored By: Senator Tillis, Thomas [R-NC]
Introduced
Summary
Equalize the negotiation timeline for small-molecule drugs and biologics under the Drug Price Negotiation Program. The bill would change how many years must pass after a drug's approval before a negotiated price can first apply.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Delays Medicare drug price negotiations
This bill would change when a drug can first be subject to Medicare price negotiation. For initial price years 2026 and 2027, a drug would need to be at least 7 years past approval. For initial price years 2028 and later, a drug would need to be at least 11 years past approval. If enacted, this could delay when Medicare and beneficiaries see lower negotiated prices for some drugs.
Sponsors & CoSponsors
Sponsor
Tillis, Thomas [R-NC]
NC • R
Cosponsors
Sen. Budd, Ted [R-NC]
NC • R
Sponsored 3/4/2025
Sen. Blackburn, Marsha [R-TN]
TN • R
Sponsored 3/4/2025
Sen. Daines, Steve [R-MT]
MT • R
Sponsored 3/4/2025
Sen. Lankford, James [R-OK]
OK • R
Sponsored 3/4/2025
Sen. Curtis, John R. [R-UT]
UT • R
Sponsored 4/10/2025
Sen. Marshall, Roger [R-KS]
KS • R
Sponsored 4/29/2025
Sen. Banks, Jim [R-IN]
IN • R
Sponsored 4/29/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov